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Transcatheter device closure of atrial septal defect (ASD) in small children less than 15 kg
may be associated with increased complications. Complete atrioventricular heart block
(CHB) is a rare complication of ASD device closure in such a setting. We report the case of a
2-year-old girl, less than 15 kg, who underwent device closure of ASD with Amplatzer
Septal Occluder and subsequently developed CHB 12 h after the procedure which resolved
completely with steroid treatment on fifth day. Case report of a similar kind is rarely re-
ported in the literature. Despite adequate postero-inferior margin CHB may still occur in
small children as in our case.
Copyright ª 2014, Cardiological Society of India. All rights reserved.1. Introduction
Due to development in device technology, transcatheter ASD
device closure is being increasingly attempted in small chil-
dren these days. A recent study in device closure of ASD in
small children weighing less than 15 kg has reported a higher
incidence of major and minor complications (5.5% and 9.4%
respectively).1 The atrioventricular conduction blocks (AVB)
after device closure of ASDs is less commonly reported than
after Ventricular Septal Defect closure. The reported incidence
of AVB following ASD device closure varies widely from none
up to 6.1%.1e4; fax: þ91 172 2744401.
com (M.K. Rohit).
ciety of India. All rights2. Case report
A 2-year-old girl, presented with history of failure to thrive
and recurrent lower respiratory tract infections since the age
of 2months. She was 88 cm tall and weighed 10.6 kg. Physical
examination was suggestive of ASD. Baseline 12-lead elec-
trocardiogram (EKG) showed normal sinus rhythm with no
conduction delays. Transthoracic 2D echocardiography
showed a 15 mm ostium secundum ASD with adequate su-
perior, posterior and inferior rims and dilated right atrium and
right ventricle. Pulmonary arterial pressure was normal and
ratio of pulmonary to systemic flow (Qp/Qs) was 2.9:1. Threereserved.
Fig. 1 e Post procedural 2D echocardiogram (Apical 4
chamber view) demonstrated ASD device in position.
There was no impingement on the atrioventricular valves.
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device closure of ASD was carried out under general anes-
thesia with 18 mm Amplatzer Septal Occluder device (ASO).
EKG monitoring during the procedure was within normal
limits. Post procedure 2D echocardiography showed no re-
sidual shunt and there was no impingement on atrioventric-
ular valves (Fig. 1). EKG monitoring at 12 h showed complete
heart block (CHB) with a ventricular rate of 75 beats per min-
ute (Fig. 2). The patient was asymptomatic and hemodynam-
ically stable. She was started on a course of oral prednisoloneFig. 2 e EKG at 12 h of ASD device deployment showed at
Fig. 3 e EKG at fifth day showed normal sinus rhyat 2 mg/kg/day and aspirin at a dose of 10 mg/kg/day to
decrease the inflammation and edema around the AV node
thought to cause the conduction problems. On day 5 of steroid
treatment, patient reverted to normal sinus rhythm with no
conduction delays or blocks (Fig. 3). A 7-day course of steroids
was administered in the hospital, and patient was discharged
to homewith a prescription of aspirin for 3months and a 5-day
steroid taper. At 9 months of follow up she continues to
remain asymptomatic and in normal sinus rhythm with no
recurrence of heart block.3. Discussion
CHB after ASD device closure is rarely reported in the
literature (Table 1). Conduction defects may be present in
patients with ASDs at baseline, possibly due to hemodynamic
changes and the proximity of the AV node in the triangle of
Koch to the location of the defects. Further, this anatomic
location predisposes any procedure for repair of the septal
defect to cause a disturbance in the conduction. This risk of
arrhythmias in the course of open surgical repair ranges from
10 to 30% whereas after percutaneous device closure it is
about 1e6%.2,3,5 The onset may be as early as during device
deployment even before the device is released to as late as few
days to weeks. One of the case reports illustrates late pro-
gression of first degree AVB to complete heart block four years
after ASD device closure.6 In our experience of 153 patients of
ASD device implantation, this is the first case of CHB we have
encountered, which spontaneously reverted with steroidrioventricular dissociation and complete heart block.
thm with resolution of complete heart block.
Table 1 e Important studies on ASD device closure and AVB.
Studies Number of patients
who underwent ASD
device closure
Number of patients who
developed high grade AVB
Fate of AVB
Hausdorf (7) 41 4 All reverted
Chan (8) 100 1 Transient CHB, reverted
Du (2) 423 e ASD device
closure with ASO
154 e Open heart surgery
1 Permanent CHB presenting
after 6 months, requiring permanent
pacemaker implantation (PPI)
Nehgme (6) 173 1 CHB developed four years later, requiring PPI
Sudha (4) 162 10 (4 e first degree AVB,
4 e second degree AVB,
2 e CHB) One had aggravation
of pre-existing AVB
In 3 patients AVB developed during procedure.
In other 7 patients AVB developed one day to one
week later. All AVB resolved or improved
spontaneously without any recurrence
Bartakian (1) 128 (weight <15 kg) 3 In one patient (41 month old) ASD device was
removed due to cardiac arrest due to CHB and
surgical referral was done. In the second patient,
procedure was abandoned due to development of CHB.
Temporary pacing was done. CHB reverted to
1st-degree HB. After 4 months she underwent
successful device closure.
In the third patient (37 month old) 24-mm Amplatzer
septal device was removed due to CHB and repeat
percutaneous ASD device closure was done successfully
after one year of follow-up
Chessa (9) 417 1 CHB recovered 3 h after percutaneous device retrieval
Wang (10) 197 1 Transient CHB, reverted to first degree AVB after 3 days
Al-Anani (11) 3000 (ASD and PFO
device closure)
2 Both patients developed AVB within 48 h and did not
respond to steroid. Both underwent surgical device
removal and ASD closure by1week.
Manoj K. Rohit 153 1 CHB developed after 12 h of device closure and
resolved after 5 days of steroid and NSAID therapy
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risk factor for development of CHB. But in our patient, CHB
developed despite adequate postero-inferior rim.
The etiology of the conduction blocks after ASD device
closure has been attributed atleast partly to the inflammation
and edema caused around the AV node by the atrial discs.
This is one of the bases for the administration of steroids
empirically in such cases, along with evidence from studies
on conduction blocks after device closure of ventricular
septal defects.7 However there have been cases in which
steroids have not helped and hence the recommendations on
this issue are not quite clear.6,8 In our case we could only
hypothesize that the cause of CHB is the inflammatory
edema and transient ischemia of the AV node secondary to
mechanical irritation by ASD device, which responded with
anti-inflammatory therapy. Risk factors for development of
AVB include hemodynamically significant defect with QP/QS
ratio >2.8, larger defects, greater device/height ratio, larger
devices, short distance between right atrial disk to tricuspid
valve, deficient postero-inferior rim <5 mm, and weight
<15 kg.1,4,8,94. Conclusion
Transcatheter ASD device closure in small children may be
associated with increased complications and completely
reversible CHB in such patients is rarely reported. Despite
adequate postero-inferior margin CHBmay still occur in smallchildrenas in our case.CHB is a rare butworrying complication
of ASD device closure, especially occurring in high-risk pa-
tients. Though in most of the cases it is a transient phenome-
non resolving either spontaneously orwith anti-inflammatory
therapy, in some of the case it requires surgical removal of the
device and closure of ASD. Timing of surgery is crucial as it has
to be done before irreversible damage of AV node, after which
the only salvage is by permanent pacemaker implantation.Conflicts of interest
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